noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

FCC - Federal Communications[...]

REPORT WC-16-233 Common Carrier Annual Employment Report
FCC - Federal Communications[...]

COMMENT SB-RM-11975 Request For Comment On Petition For Rulemaking By[...]
FCC - Federal Communications[...]

LETTER WC-19-126 Rural Digital Opportunity Fund

Healthcare

BioXcel Therapeutics Inc.

12/01/2021 | Press release | Distributed by Public on 12/01/2021 06:07

BioXcel Therapeutics Announces Extension of FDA Review Period of its NDA for BXCL501 for the Acute Treatment of Agitation Associated with Schizophrenia and Bipolar Disorders

Sharing and Personal Tools

Please select the service you want to use:

Back

Download the original document